Cite
MLA Citation
M. Früh et al.. “Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts.” Lung cancer, vol. 146, 2020, pp. 6–11. http://access.bl.uk/ark:/81055/vdc_100105147764.0x000048